Nutritional and developmental programming effects of insulin

The discovery of insulin in 1921 was a major breakthrough in medicine and for therapy in patients with diabetes. The dramatic rise in the prevalence of overweight and obesity has been tightly linked to an increased prevalence of gestational diabetes mellitus (GDM), which poses major health concerns. Babies born to GDM mothers are more likely to develop obesity, type 2 diabetes and cardiovascular disease later in life. Evidence accumulated during the past two decades has revealed that high levels insulin, such as those observed during GDM, can have a widespread effect on the development and function of a variety of organs. This review summarises our current knowledge on the role of insulin in the placenta, cardiovascular system and brain during critical periods of development, as well as how it can contribute to lifelong metabolic regulation. We also discuss possible intervention strategies to ameliorate and hopefully reverse the developmental defects associated with obesity and GDM.

Automated summary

The discovery of insulin in 1921 was a major breakthrough in medicine, with implications for patients with diabetes. High levels of insulin observed during GDM can have a widespread effect on organ development and function, leading to long-term health concerns such as obesity, type 2 diabetes, and cardiovascular disease in offspring. Strategies to intervene and reverse developmental defects associated with obesity and GDM are also discussed.